European Business
  • HOME
  • SUSTAINABILITY
  • INVEST
  • MARKET
  • PARTNERSHIP
  • INNOVATION
  • PEOPLE
  • INSIGHTS
No Result
View All Result
European Business
  • HOME
  • SUSTAINABILITY
  • INVEST
  • MARKET
  • PARTNERSHIP
  • INNOVATION
  • PEOPLE
  • INSIGHTS
No Result
View All Result
European Business
No Result
View All Result
Home < INDUSTRIES Health

Merck Announces New Appointments in Global R&D and Strategy Leadership for Healthcare Business Sector

by Marie Weil
January 14, 2022
A A
Share on LinkedinShare on Twitter

Merck today announced new appointments in Global R&D and Strategy leadership for the Healthcare business sector.

Darmstadt, Germany, January 13, 2022 – Merck, a leading science and technology company, today announced new appointments in Global R&D and Strategy leadership for the Healthcare business sector. Danny Bar-Zohar, MD, will become Global Head of R&D and Joern-Peter Halle, PhD, will become Chief Strategy Officer.

“At the critical intersection of R&D and Strategy is a very unique opportunity to make bold choices that best position us to deliver on our fullest innovative potential for patients and for Merck,” said Peter Guenter, Member of the Executive Board of Merck, and CEO Healthcare. “With Danny and Joern-Peter, we have the perfect combination of collaboration, strategic vision and leadership, in addition to world-class experience and expertise, to move beyond the status quo and lead our innovation engine for today and for the future.”

As Global Head of R&D, Bar-Zohar will lead Research and Development, including Medical Affairs. Bar-Zohar joined Merck in November 2020 as Executive Vice President, Global Head of Development. He has more than a decade of leadership experience in pharma, having worked previously at Novartis and Teva. He brings global drug development experience from strategy to execution to this position, across almost every modality in drug development, including small molecules, therapeutic proteins, antibodies and gene therapy. Bar-Zohar’s proven track record will serve to further advance the highly innovative and differentiated early-stage assets the Merck research teams have delivered into development in recent years.

As Chief Strategy Officer, Halle will lead Strategy and Business Development. Halle brings significant experience to this role, having previously served as Executive Vice President, Global Head of Research for the last 18 months, leading discovery through pre-clinical efforts for the company’s Oncology/Immuno-Oncology and Immunology therapeutic areas. Halle also served as Senior Vice President, Head of Immuno-Oncology research, and Senior Vice President, Head of External Innovation. Halle brings more than 25 years of industry experience to this position. He joined Merck in 2005.

Both Bar-Zohar and Halle will continue to be part of the Healthcare Executive Committee and be based at the company’s global headquarters in Darmstadt, Germany.

Tags: < PEOPLE

Related Industries

Health

Dr. Jost Reinhard appointed new head of Investor Relations at Bayer

September 20, 2023
Health

Sandoz completes acquisition of leading antifungal agent Mycamine® from Astellas, reinforcing leading global anti-infectives portfolio

August 29, 2023
Health

Bayer appoints Dr. Juergen Eckhardt as new Head of Pharmaceuticals Business Development & Licensing / Open Innovation

August 23, 2023
Health

Innovative research for malaria control driven by three collaborating parties: Swiss TPH, BASF and Promega

August 18, 2023
Health

SSM Health, Siemens Healthineers partner to advance health equity and empower workforce development in underserved communities

August 15, 2023
Health

3M completes sale of dental local anesthetic portfolio assets to Pierrel

August 2, 2023

Ericsson and M1 partner to deploy the new generation of 5G routers to enable a future- ready mobile transport network

September 1, 2023

...

Manja Greimeier Appointed New Head of Original Equipment for Continental’s Tires Group Sector

September 1, 2023

...

GE Vernova awarded bulk order by Amprion for power interconnection transformers to reinforce electrical grid in Germany

September 20, 2023

...

BASF is paving the way for an infinite range of sustainable plastic solutions at Fakuma 2023

September 20, 2023

...

L’Oréal completes acquisition of Aesop

August 31, 2023

...

Talking not Typing: Continental and Google Cloud Equip Cars with Generative Artificial Intelligence IAA MOBILITY 2023

September 5, 2023

...

A new Internet Levy threatens Europe’s Creative Industries and Digital Decade targets

September 16, 2023

...

Stellantis Celebrates Opening of Its First Battery Technology Center in Italy

September 9, 2023

...

Amelia IRION appointed Vice President Human Resources for Air Liquide, effective September 18, 2023

September 8, 2023

...

Bringing the power of Dow innovation to Labelexpo Europe 2023

September 6, 2023

...

Asia Pacific Business Asia Pacific Business Asia Pacific Business

EUROPEAN BUSINESS is a premier source of corporate news, business information and insights across broad spectrum of industries in Europe and worldwide.  We are one of the members of the Business World Network.

RESOURCES

  • HOME
  • SUSTAINABILITY
  • INVEST
  • MARKET
  • PARTNERSHIP
  • INNOVATION
  • PEOPLE
  • INSIGHTS

CONTACT US

EDITORIAL:     editor # european-biz.com

PARTNERSHIP:     partnership # european-biz.com

HUMAN RESOURCE:     hr # european-biz.com

* (replace # with @)

  • Official Site

Copyright © EUROPEAN-BIZ.COM All rights reserved.

No Result
View All Result
  • HOME
  • SUSTAINABILITY
  • INVEST
  • MARKET
  • PARTNERSHIP
  • INNOVATION
  • PEOPLE
  • INSIGHTS

Copyright © EUROPEAN-BIZ.COM All rights reserved.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In

Add New Playlist